Parmax Pharma Closes Trading Window April 1 for FY26 Earnings

SEBIEXCHANGE
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Parmax Pharma Closes Trading Window April 1 for FY26 Earnings
Overview

Parmax Pharma Limited will close its trading window for employees and directors starting April 1, 2026. This standard move complies with insider trading rules and aims to prevent the misuse of non-public financial information before results are announced. The window will reopen 48 hours after the company releases its financial results for the year ending March 31, 2026.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Trading Window Closure Announced

Parmax Pharma Limited announced it will close its trading window for designated persons starting April 1, 2026. This measure precedes the company's upcoming announcement of its financial results for the quarter and fiscal year ending March 31, 2026.

Purpose of the Closure

This standard practice is implemented in accordance with SEBI's insider trading regulations. Its primary goal is to prevent the misuse of any unpublished price-sensitive information by company insiders before it is made public. This upholds market integrity and ensures fair trading.

Company Background

Parmax Pharma Limited is a pharmaceutical company involved in manufacturing and marketing diverse products, including bulk drugs (APIs) and formulations.

Reopening the Window

The trading window is expected to reopen 48 hours after the company officially declares its financial results for the period. The company will announce the date of the board meeting scheduled to approve these results.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.